Old Web
English
Sign In
Acemap
>
Paper
>
DOP006 A multicentre cohort study to assess the safety of vedolizumab for inflammatory bowel disease
DOP006 A multicentre cohort study to assess the safety of vedolizumab for inflammatory bowel disease
2018
Joseph Meserve
Satimai Aniwan
Jenna L. Koliani-Pace
Preeti Shashi
A Weiss
David Faleck
Adam Winters
Shreya Chablaney
Gursimran Kochhar
Brigid S. Boland
Sharat Singh
Robert Hirten
Eugenia Shmidt
Matthew Bohm
Sashidhar Sagi
Monika Fischer
Dana J. Lukin
David Hudesman
Shannon Chang
Keith Sultan
Arun Swaminath
Nitin Gupta
Sunanda V. Kane
E.V. Loftus
Bo Shen
B. Sands
J.-F. Colombel
Corey A. Siegel
W.J. Sandborn
Parambir S. Dulai
Keywords:
Physical therapy
Vedolizumab
Cohort study
Inflammatory bowel disease
Medicine
Internal medicine
Diabetes mellitus
Correction
Source
Cite
Save
0
References
0
Citations
NaN
KQI
[]
map